← Back to Clinical Trials
Recruiting NCT07379814

NCT07379814 Rectus Abdominis Detrusor Myoplasty for Urinary Retention

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07379814
Status Recruiting
Phase
Sponsor University Hospitals Cleveland Medical Center
Condition Urinary Retention
Study Type OBSERVATIONAL
Enrollment 50 participants
Start Date 2026-05-01
Primary Completion 2036-05-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 75 Years
Study Type OBSERVATIONAL
Interventions
Rectus Abdominal Detrusor Myoplasty

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 50 participants in total. It began in 2026-05-01 with a primary completion date of 2036-05-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This investigates the outcomes of a surgical technique using the patient's own abdominal wall muscles to help contract the bladder in patients with urinary retention

Eligibility Criteria

Inclusion Criteria: * Hypo- or acontractility of the bladder documented on urodynamic testing * Injury \>1 year ago for spinal cord injury patients, no improvement in contractility with time * Failed sacral nerve stimulation implant for urinary retention treatment (If previously implanted) * Irreversible non-neurogenic bladder acontractility/hypocontractility (i.e myogenic failure after chronic obstruction, aging, frailty, idiopathic) * Undergoing RADM Exclusion Criteria: * Documented bladder outlet obstruction * Spinal cord lesion above T12 * Upper motor neuron lesion (i.e. multiple sclerosis, stroke) * Rectus diastasis, significant abdominal wall hernia, or other anatomic barrier to rectus flap harvest * Life expectancy \<10 years * Pregnant at time of surgery

Contact & Investigator

Central Contact

Seyed Sajjad Tabei

✉ seyedsajjad.tabei@uhhospitals.org

📞 216-844-8963

Principal Investigator

Shubham Gupta, MD

PRINCIPAL INVESTIGATOR

University Hospitals Cleveland

Frequently Asked Questions

Who can join the NCT07379814 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Urinary Retention. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07379814 currently recruiting?

Yes, NCT07379814 is actively recruiting participants. Contact the research team at seyedsajjad.tabei@uhhospitals.org for enrollment information.

Where is the NCT07379814 trial being conducted?

This trial is being conducted at Cleveland, United States.

Who is sponsoring the NCT07379814 clinical trial?

NCT07379814 is sponsored by University Hospitals Cleveland Medical Center. The principal investigator is Shubham Gupta, MD at University Hospitals Cleveland. The trial plans to enroll 50 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology